Argus
•
Aug 23, 2023
ANIK: What does Argus have to say about ANIK?
Summary
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
LGND: Raising target price to $313.00
Sep 02, 2026
•
LGND
ANIP: Lowering target price to $68.00
Sep 02, 2026
•
ANIP
AMPH: Raising target price to $24.00
Sep 02, 2026
•
AMPH
CYTK: Lowering target price to $75.00
Sep 02, 2026
•
CYTK
AMSF: Lowering target price to $23.00
Sep 02, 2026
•
AMSF
